ZOLADEX - 0310-0951-30 - (Goserelin acetate)

Alphabetical Index


Drug Information of ZOLADEX

Product NDC: 0310-0951
Proprietary Name: ZOLADEX
Non Proprietary Name: Goserelin acetate
Active Ingredient(s): 10.8    mg/1 & nbsp;   Goserelin acetate
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): IMPLANT
Coding System: National Drug Codes(NDC)

Labeler Information of ZOLADEX

Product NDC: 0310-0951
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020578
Marketing Category: NDA
Start Marketing Date: 20030505

Package Information of ZOLADEX

Package NDC: 0310-0951-30
Package Description: 1 POUCH in 1 CARTON (0310-0951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE

NDC Information of ZOLADEX

NDC Code 0310-0951-30
Proprietary Name ZOLADEX
Package Description 1 POUCH in 1 CARTON (0310-0951-30) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE
Product NDC 0310-0951
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Goserelin acetate
Dosage Form Name IMPLANT
Route Name SUBCUTANEOUS
Start Marketing Date 20030505
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name GOSERELIN ACETATE
Strength Number 10.8
Strength Unit mg/1
Pharmaceutical Classes Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA]

Complete Information of ZOLADEX


General Information